Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Cholera
Measles
SAGE documentation
2017
Clear all
Type of publications
NITAG documentation
(3)
SAGE documentation
(12)
Systematic reviews (SYSVAC)
(7)
Topics
Evidence to recommendation table
(2)
GRADE table
(7)
Position paper
(2)
SAGE background document
(1)
Regions
Countries
Diseases
Cholera
(2)
Measles
(10)
Dengue
(1)
Diphtheria
(3)
Hepatitis B
(3)
Human papillomavirus (HPV)
(10)
Pneumococcal disease
(3)
Poliomyelitis
(1)
Rabies
(3)
Tetanus
(1)
Typhoid
(4)
Yellow fever
(1)
Publication date
2017
(12)
2022
(6)
2018
(1)
2016
(2)
2015
(1)
2010
(1)
2009
(1)
Target population
Available to download in languages
English (EN)
(12)
French (FR)
(2)
12 results found
2017
∙
SAGE
Effectiveness of measles vaccine in young children and adolescents
2017
∙
SAGE
Should SAGE recommend the removal of the criterion that MCV2 only be given if MCV1 coverage is >80% for the introduction of routine measles second dose as stated in the 2009 measles vaccine position paper?
2017
∙
SAGE
Systematic literature review and meta-analyses of the benefits and risks of measles vaccination below 6 months of age
2017
∙
SAGE
Safety of the measles vaccine in young children and adolescents
2017
∙
SAGE
Duration of protection following measles immunization
2017
∙
SAGE
Should an additional dose of measles-containing vaccine be recommended for HIV-infected adolescents and adults?
2017
∙
SAGE
Measles revaccination of HIV-infected children receiving highly active antiretroviral therapy
2017
∙
SAGE
Should HIV-infected children receiving highly active antiretroviral therapy be revaccinated against measles?
2017
∙
SAGE
Safety in HIV infected children
2017
∙
SAGE
Measles vaccines: WHO position paper
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register